Anthera Pharmaceuticals Inc Share Price Nasdaq
Equities
US03674U2015
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2018 | Anthera Pharmaceuticals, Inc.(OTCPK:ANTH) dropped from S&P TMI Index | CI |
2018 | Anthera Pharmaceuticals, Inc.(OTCPK:ANTH) dropped from NASDAQ Composite Index | CI |
Sales 2016 | 0.14 12.11 | Sales 2017 | - | Capitalization | 22.85M 1.91B |
---|---|---|---|---|---|
Net income 2016 | -55M -4.59B | Net income 2017 | -26M -2.17B | EV / Sales 2016 | 4,40,69,434 x |
Net cash position 2016 | 20.84M 1.74B | Net cash position 2017 | 2.2M 183M | EV / Sales 2017 | - |
P/E ratio 2016 |
-0.4
x | P/E ratio 2017 |
-0.58
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+3.76% | 108B | |
+11.06% | 104B | |
+1.28% | 22.33B | |
-12.79% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.23% | 17.64B | |
+3.62% | 14.05B | |
+37.24% | 12.51B |